-
Featured Post
TECPR2 Research Foundation and Forge Biologics Announce AAV Development and Manufacturing Partnership to Advance Gene Therapy for TECPR2
Read more: TECPR2 Research Foundation and Forge Biologics Announce AAV Development and Manufacturing Partnership to Advance Gene Therapy for TECPR2“That mission has brought together an incredible group of scientists and partners who believe, as we do, that children with ultra-rare diseases deserve the same opportunity for scientific progress as anyone else.”